{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-029592","form_type":"8-K","ticker":"RMTI","cik":"0001041024","company_name":"ROCKWELL MEDICAL, INC.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.365375+00:00","generated_at":"2026-06-21T19:16:12.110901+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rockwell Medical posts record Q3 revenue of $18.7M; cuts debt to $10M; targets 2024 profitability","bullets":["Q3 revenue $18.7M (+16.9% YoY), highest quarterly revenue; FY2022 guidance $65-70M.","Cash used in ops $1.1M (down 81% QoQ); cash balance $27.6M, adjusted $22.6M after debt prepayment.","Reduced long-term debt from $15M to $10M via $5M prepayment; 10-month interest-only period starts Dec 2022.","Reacquired distribution rights from Baxter, adding 700+ hemodialysis customers; targets $100M annual revenue.","Discontinued US NDAs for TRIFERIC (saves $2-3M/yr); paused FPC Home Infusion; workforce reductions."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-029592","json":"https://secwatch.observer/filing/0001628280-22-029592.json","markdown":"https://secwatch.observer/filing/0001628280-22-029592.md","text":"https://secwatch.observer/filing/0001628280-22-029592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041024/000162828022029592/0001628280-22-029592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041024/000162828022029592/rmti-20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T19:16:12.110901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"151cd11075b685fc8337f28fb6d8e78680154a71","claim":"ROCKWELL MEDICAL, INC. reported third quarter ended September 30, 2022 results: revenue $18.7 million.","evidence_excerpt":"Revenue for the three months ended September 30, 2022 was $18.7 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828022029592/0001628280-22-029592-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$18.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}